Group One Trading
FUSN

Group One Trading’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Group One Trading’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-41,100
Closed -$876K – 7706
2024
Q1 		$876K Buy
41,100
+16,400
+66% +$196K ﹤0.01% 2213
2023
Q4 		$237K Buy
+24,700
New +$120K ﹤0.01% 3717
2023
Q3 		– Sell
-100
Closed -$467 – 8492
2023
Q2 		$467 Buy
+100
New +$432 ﹤0.01% 7377

Group One Trading's FUSN Position: Q1 2024 in Review

Group One Trading sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q1 2024, closing a stake of 19,134 shares — an estimated $229K sold.

Group One Trading first reported a position in FUSN in Q4 2023 and held it in 1 quarter. The position peaked at $184K in Q4 2023. 114 funds tracked by Wall St. Rank hold FUSN as of Q1 2024.

  • Group One Trading reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 19,134 Fusion Pharmaceuticals Inc. Common Shares shares in Q1 2024, an estimated $229K.
  • Group One Trading first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 1 quarter.
  • Group One Trading's Fusion Pharmaceuticals Inc. Common Shares position peaked at $184K in Q4 2023.
  • 114 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.